We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.22B
AUM Growth
-$44.8M
Cap. Flow
+$3.01M
Cap. Flow %
0.25%
Top 10 Hldgs %
29.85%
Holding
194
New
3
Increased
55
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$950K
2
CB icon
Chubb
CB
+$761K
3
BLKB icon
Blackbaud
BLKB
+$689K
4
HXL icon
Hexcel
HXL
+$638K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$628K

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$1.84M
2
FDX icon
FedEx
FDX
+$1.8M
3
MSFT icon
Microsoft
MSFT
+$1.69M
4
SNPS icon
Synopsys
SNPS
+$1.41M
5
AAPL icon
Apple
AAPL
+$727K

Sector Composition

Rank Sector Weight
1 Technology 27.18%
2 Healthcare 16.06%
3 Industrials 11.8%
4 Financials 11.68%
5 Consumer Staples 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
101
Kimberly-Clark
KMB
$37.6B
$840K 0.07%
7,425
-451
-6% -$58.6K
TSLA icon
102
Tesla
TSLA
$1.18T
$830K 0.07%
3,144
ISRG icon
103
Intuitive Surgical
ISRG
$127B
$810K 0.07%
4,311
ABBV icon
104
AbbVie
ABBV
$465B
$790K 0.06%
5,915
WAT icon
105
Waters Corp
WAT
$37.3B
$780K 0.06%
2,910
PM icon
106
Philip Morris
PM
$309B
$770K 0.06%
9,325
-20
-0.2% -$1.91K
J icon
107
Jacobs Solutions
J
$16B
$750K 0.06%
8,329
FUL icon
108
H.B. Fuller
FUL
$3B
$730K 0.06%
12,094
HUBB icon
109
Hubbell
HUBB
$24.4B
$720K 0.06%
3,217
NEE icon
110
NextEra Energy
NEE
$184B
$720K 0.06%
9,208
TGT icon
111
Target
TGT
$66.3B
$710K 0.06%
4,816
V icon
112
Visa
V
$701B
$710K 0.06%
3,988
BDX icon
113
Becton Dickinson
BDX
$46.4B
$700K 0.06%
3,149
VEU icon
114
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$700K 0.06%
15,730
AZN icon
115
AstraZeneca
AZN
$269B
$690K 0.06%
6,333
-246
-4% -$31.2K
VHT icon
116
Vanguard Health Care ETF
VHT
$18.5B
$680K 0.06%
3,045
ORCL icon
117
Oracle
ORCL
$339B
$670K 0.05%
11,034
BP icon
118
BP
BP
$112B
$660K 0.05%
22,993
NVO
119
Novo Nordisk
NVO
$228B
$660K 0.05%
13,334
-100
-0.7% -$5.36K
VPL icon
120
Vanguard FTSE Pacific ETF
VPL
$7.77B
$660K 0.05%
11,450
+600
+6% +$38.3K
GE icon
121
GE Aerospace
GE
$364B
$600K 0.05%
15,661
-133
-0.8% -$5.85K
WST icon
122
West Pharmaceutical
WST
$23.7B
$500K 0.04%
2,018
LOW icon
123
Lowe's Companies
LOW
$121B
$490K 0.04%
2,606
DE icon
124
Deere & Co
DE
$165B
$480K 0.04%
1,437
-100
-7% -$34.3K
ACN icon
125
Accenture
ACN
$106B
$450K 0.04%
1,757

Similar funds

Grandfield & Dodd's Q3 2022 Portfolio in Review

As of Q3 2022, Grandfield & Dodd held 194 positions worth $1.22B, down 3.5% from $1.27B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q3 2022 filing shows 3 new, 55 increased, 48 reduced and 9 closed positions. Its largest new stake was Genmab: 10,210 shares worth $330K. The largest sale was Brunswick, an estimated $1.84M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q3 2022 buy was Genmab: 10,210 shares worth $330K.
  • Grandfield & Dodd added most to People Inc in Q3 2022, an estimated $950K increase.
  • Grandfield & Dodd's biggest Q3 2022 reduction was Brunswick, cutting an estimated $1.84M.
  • Grandfield & Dodd fully exited Verizon in Q3 2022, selling an estimated $420K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.22B portfolio in Q3 2022.
  • Grandfield & Dodd opened 3 new positions and closed 9 in Q3 2022.
  • Grandfield & Dodd's portfolio value fell 3.5% quarter-over-quarter to $1.22B.

Based on Grandfield & Dodd's 13F filing for Q3 2022, filed 4 Nov 2022.